The Effect of Virtual Reality Exercises on Patients With Post-SARS-CoV-2 Syndrome

Covid19 Clinical Trial

Official title:

The Effect of Virtual Reality Exercises on Pain, Cardiopulmonary Functional Capacity and Quality of Life in Patients With Post-COVID Syndrome

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04983394
• Other study ID #: SivasCumhuriyetUniversity
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 1, 2021
• Est. completion date: May 1, 2022

Study information

• Verified date: March 2022
• Source: Cumhuriyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to investigate the effectiveness of virtual reality exercises on pain, cardiopulmonary capacity, mood and quality of life in patients with post-COVID syndrome.

Description:

This study, which will be conducted in Sivas Cumhuriyet University, Physical Medicine and Rehabilitation Clinic, was diagnosed with COVID-19 from an oropharyngeal or nasopharyngeal swab sample more than 90 days ago with polymerase chain reaction, whose symptoms have continued since the diagnosis of COVID-19, and inpatient treatment. 63 adult female and male post-COVID syndrome patients who did not develop pneumonia or organ failure findings will be included. Those who have had acute myocardial infarction in the last 6 months, have cardiovascular system disease such as uncontrolled hypertension, arrhythmia, aneurysm, cardiac failure, have undergone fracture or orthopedic surgery in the last 3 months, have a known chronic respiratory system disease, cause widespread pain such as fibromyalgia syndrome Those who have a disease or cannot be mobilized independently will not be included in the study. The sample size was determined as d=0.80 α=0.05 p=0.80410 n=54 using the G*Power 3.1.9.4 program. Considering the 15% drop-out risk, 63 patients were planned to be included.

Demographic data of all participants, including age, gender, height, weight and body mass index, and the time elapsed since the diagnosis of COVID-19 will be recorded. In addition, participants' pain intensity, functional capacity, general health status, mood, and fatigue levels will be evaluated.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 63
• Est. completion date: May 1, 2022
• Est. primary completion date: January 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• diagnosed with COVID-19 by polymerase chain reaction from an oropharyngeal or nasopharyngeal swab sample more than 90 days ago, whose symptoms have continued since the diagnosis of COVID-19

Exclusion Criteria:

• have been hospitalized due to COVID-19,

• have developed pneumonia or organ failure findings.

• have had an acute myocardial infarction in the last 6 months,

• have cardiovascular system disease such as uncontrolled hypertension, arrhythmia, aneurysm, cardiac failure,

• have undergone fracture or orthopedic surgery in the last 3 months,

• have a known chronic respiratory system disease,

• have widespread pain such as fibromyalgia syndrome

Related Conditions & MeSH terms

• Covid19

Intervention

Other:
• Virtual Realty Exercises
motion-controlled video game
• Aerobic exercises
cycling activity
• conventional exercises
stretching, strengthening and endurance exercises

Locations

Country	Name	City	State
Turkey	Sivas Cumhuriyet University	Sivas

Sponsors (1)

Lead Sponsor	Collaborator
Cumhuriyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	visual Analogue Scale		8th week
Secondary	hospital anxiety and depression scale-Depression		0th and 8th week
Secondary	hospital anxiety and depression scale-Anxiety		0th and 8th week
Secondary	Fatigue severity scale		0th and 8th week
Secondary	Short Form-12		0th and 8th week
Secondary	6 minutes walking test		0th and 8th week